P. Schmid
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Cancer Treatment and Pharmacology 2
- PARP inhibition in cancer therapy 1
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Hope S. Rugo (2 shared papers)Hiroji Iwata (1 shared paper)Shilpen Patel (1 shared paper)Eric P. Winer (1 shared paper)Véronique Dièras (1 shared paper)S.Y. Chui (1 shared paper)Luciana Molinero (1 shared paper)Andreas Schneeweiß (1 shared paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
P. Schmid
4 papers receiving 354 citations
P. Schmid's Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 235
- Cancer Research 77
- Pulmonary and Respiratory Medicine 101
- Immunology 52
- Radiology, Nuclear Medicine and Imaging 17
Countries citing papers authored by P. Schmid
This map shows the geographic impact of P. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schmid more than expected).
Fields of papers citing papers by P. Schmid
This network shows the impact of papers produced by P. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schmid. The network helps show where P. Schmid may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis Hit paper breakdown → | 2021 | 311 |
| 2 | 2022 | 42 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 |
About P. Schmid
P. Schmid is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 361 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Genomics and Diagnostics (1 paper) and PARP inhibition in cancer therapy (1 paper). The work is most often cited by research in Oncology (235 citations), Cancer Research (77 citations), Pulmonary and Respiratory Medicine (101 citations), Immunology (52 citations) and Radiology, Nuclear Medicine and Imaging (17 citations). P. Schmid has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hope S. Rugo, Hiroji Iwata, Shilpen Patel, Eric P. Winer, Véronique Dièras, S.Y. Chui, Luciana Molinero, Andreas Schneeweiß, Carlos H. Barrios and Leisha A. Emens. Their work appears in journals such as Annals of Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.